I spent six months trying to find a skincare routine that worked. Not a perfect routine — just one that met three criteria: effective, simple enough to maintain with an ADHD brain, and compatible with frequent travel. I used AI to score every leading product against these criteria. The best score was 65%. That number broke something in me — the realisation that the entire industry had optimised for everything except the user's actual life.
The products that worked were too complex. The simple ones did not perform. Almost everything came with fragrance I did not want, packaging I could not recycle, or preservative systems that irritated my skin. I was not looking for luxury. I was looking for competence — a product that could do its job without demanding attention, ritual, or a second mortgage.
I came from brand strategy, not formulation chemistry. That turned out to be an advantage. I approached the problem from the user's perspective first — what does a daily skincare protocol actually need to be? — and worked backward to the formulation. The answer was not a better product in each category. It was one product that collapsed the categories: hydration, barrier support, collagen signalling, protection, all in a single properly engineered formula.
The made-to-order model was not a marketing decision. It was a logical conclusion. If the ingredients degrade over time, and the user is the one who needs them at peak potency, the product should be made as close as possible to the time of use. Warehousing active ingredients makes no sense from a biological perspective. It only makes sense from a distribution perspective.
NeoLabCare is not a brand that decided to do things differently. It is a brand that could not justify doing things the same way. Every decision — the single formula, the vacuum pump, the no-CD packaging, the direct-to-consumer model — is a consequence of that starting position: design from the user's biology, not the industry's convenience.